Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02192359
Brief Title: Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

First Submitted : July 15, 2014
First Submitted that Met QC Criteria : July 15, 2014
First Posted : July 16, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : October 31, 2019
Last Update Posted : November 4, 2019